Biolegend, 575308, Recombinant Mouse IFN-γ (carrier-free), 500μg

Interferon-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.
500μg
Source: Mouse IFN-γ, amino acids His23-Cys155 (Accession # NM_008337) was expressed in E. coli.
Molecular Mass: The 134 amino acid N-terminal methionylated recombinant protein has a predicted molecular mass of 15,652 Da. The DTT-reduced and non-reduced protein migrate at approximately 13 kD by SDS-PAGE.
Purity: Purity is >98%, as determined by Coomassie stained SDS-PAGE.
Formulation: 0.22 µm filtered protein solution is in 20 mM HEPES, 150 mM NaCl, 5 mM TCEP, pH 7.2.
Endotoxin Level: Endotoxin level is <0.1 EU/µg (<0.01ng/µg) protein as determined by the LAL method.
Concentration: 10 and 25 µg sizes are bottled at 100 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling: Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity: Recombinant mouse IFNγ induces cytotoxicity in L929 cells in a dose dependent manner. The ED50 of this effect is 0.5 - 3.5 ng/mLRecombinant mouse IFN-γ induces cytotoxicity in WEHI-279 cells in a dose dependent manner. The ED50 of this effect is 0.05 - 0.5 ng/mL
Application: Bioassay
Recommended Usage: Use when high specific biological activity is required.
Application Notes: BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected].
Application References(PubMed link indicates BioLegend citation): Reynolds DS, et al. 1987. J. Immunol. 139:767. (BA) Dey S, et al. 2010. Mol. Cell. Biol. 30:2181. PubMed Sun T, et al. 2012. Proc. Natl. Acad. Sci. USA 109:E2117. PubMed
Product Citations: Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed Xiao Y, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:21. PubMed Wei Z, et al. 2022. Nature. 609:348. PubMed Tsukumo SI, et al. 2022. Sci Adv. 8:eabq0008. PubMed Jiang S, et al. 2022. Sci Adv. 8:eabn6027. PubMed Mirji G, et al. 2022. Sci Immunol. 7:eabn0704. PubMed Strine MS, et al. 2022. Cell Rep. 41:111593. PubMed Mohammadpour H, et al. 2023. Cell Rep. 42:112250. PubMed Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed Castillo E, et al. 2021. J Neurochem. 159:1008. PubMed Rouanne M, et al. 2022. J Clin Invest. 132: . PubMed Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed Karino K, et al. 2023. Arthritis Rheumatol. 75:411. PubMed Jahanbazi Jahan-Abad A, et al. 2023. Glia. 71:633. PubMed Chen H, et al. 2022. Nat Commun. 13:7375. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Greer R, et al. 2016. Nat Commun. 7:13329. PubMed Kiritsy MC, et al. 2021. Elife. 10:. PubMed Mia MM, et al. 2020. PLoS Biol. 18:e3000941. PubMed Li Y, et al. 2022. J Lipid Res. :100273. PubMed Davis B, et al. 2017. J Virol. 10.1128/JVI.00889-17. PubMed Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed Yu Y, et al. 2020. FASEB J. 34:15417. PubMed Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed Inoue M, et al. 2016. Nat Neurosci. 19:1599-1609. PubMed Lin H, et al. 2019. Infect Immun. 87:e00055-19. PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed Ji DX, et al. 2021. Elife. 10: . PubMed Rai P, et al. 2021. Nat Immunol. 22:312. PubMed Wongchana W, et al. 2015. J Immunol. 195: 5337 - 5346. PubMed Miranda K, et al. 2019. Front Immunol. 10:1049. PubMed Pereira M, et al. 2022. Cell Rep. 40:111225. PubMed Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed Eissa IR, et al. 2021. Int J Cancer. 149:214. PubMed Nguyen TT, et al. 2022. Sci Adv. 8:eabn8614. PubMed Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed Chu SY, et al. 2019. Nat Commun. 10:1524. PubMed Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed Kanemaru H, et al. 2021. iScience. 24:103067. PubMed Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed Mohammadi N, et al. 2022. Front Cell Infect Microbiol. 11:784101. PubMed Shibuya M, et al. 2021. iScience. 24:103131. PubMed Prieto–Fernández E, et al. 2020. Front Immunol. 11:586977. PubMed Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed Schweickert PG, et al. 2021. J Thromb Haemost. 19:161. PubMed Fonderflick L, et al. 2022. Cells. 11:. PubMed Yu Y, et al. 2021. FASEB J. 35:e21554. PubMed Knox T, et al. 2019. Sci Rep. 9:6136. PubMed Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed Yang L, et al. 2019. Front Immunol. 10:2020. PubMed Zhou X, et al. 2022. Front Pharmacol. 13:818166. PubMed Kanemaru H, et al. 2022. STAR Protoc. 3:101128. PubMed Luna-Yolba R, et al. 2021. Cancers (Basel). 13: . PubMed Bilotta AJ, et al. 2020. Cell Mol Gastroenterol Hepatol. 1.16875. PubMed Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed Kalliara E, et al. 2022. Front Immunol. 13:947213. PubMed Hogg SJ, et al. 2022. Clin Epigenetics. 14:96. PubMed Mantsounga CS, et al. 2022. Cell Rep. 38:110309. PubMed Matei DE, et al. 2021. Med (N Y). 2:864. PubMed AuYeung AWK, et al. 2021. Sci Rep. 11:15290. PubMed
Structure: Cytokine; dimer
Bioactivity: Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APC
Cell Sources: CD8+ and CD4+ T cells, NK cells
Cell Targets: T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors: IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type: Embryonic Stem Cells
Biology Area: Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience, Stem Cells
Molecular Family: Cytokines/Chemokines
Antigen References: 1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego. 2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321. 3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571. 4. Gray P, et al. 1987. Lymphokines 13:151.
Regulation: Upregulated by IL-2, FGF-basic, EGF; downregulated by vitamin D3 or DMN; labile at pH2
Gene ID: 15978
UniProt: View information about IFN-gamma on UniProt.org
Regulatory Status: RUO
Other Names: Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF),
Q: Why choose BioLegend recombinant proteins?
A: • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.
Q: How does the activity of your recombinant proteins compare to competitors?
A: We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
Q: What is the specific activity or ED50 of my recombinant protein?
A: The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
Q: Have your recombinants been tested for stability?
A: Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
Q: Does specific activity of a recombinant protein vary between lots?
A: Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
Q: How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
A: Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)